SCHEMBL17427014

SCHEMBL17427014

CC1(C)c2ccccc2-c2cc3c(cc21)-c1ccc(-c2nccc(-c4cccc5ccccc45)n2)cc1C3(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 6/20 0.40
▸ MAPT P10636 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CCNT1 O60563 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ PDK2 Q15119 2/20 0.36
▸ HTR2A P28223 2/20 0.35
▸ ENPP3 O14638 1/20 0.34
▸ ENPP1 P22413 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14508253 0.94 HTR2C (0.43) HTR2CMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL17427013 0.86 HTR2C (0.37) HTR2CMAPTSMN1; SMN2PDK2HTR2A
SCHEMBL17427003 0.85 HTR2C (0.36) HTR2CMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL17427009 0.85 KMT2A (0.41) MAPTSMN1; SMN2MEN1KMT2APDK2
SCHEMBL17427006 0.84 HTR2C (0.34) HTR2CMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL17427038 0.83 MEN1 (0.42) MAPTSMN1; SMN2MEN1KMT2AENPP3
SCHEMBL17427017 0.83 PDK2 (0.38) HTR2CMAPTSMN1; SMN2CCNT1CCNA2
SCHEMBL18731947 0.83 S1PR1 (0.37) HTR2CMAPTSMN1; SMN2PDK2HTR2A
SCHEMBL19008455 0.83 HTR2C (0.35) HTR2CMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL17427018 0.83 PDK2 (0.38) HTR2CMAPTSMN1; SMN2CCNT1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9847492-B2 Organic compound and organic light emitting diode device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-12-19 — — US disclosed
US-9847492-B2 Organic compound and organic light emitting diode device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-12-19 — — US disclosed
US-20160013420-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-01-14 — — US disclosed
US-20160013420-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160013420-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME OXER1, AOX1, CYP1A1 HTR2C 521/4885MAPT 2522/4885SMN1; SMN2 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback